To update advances in identifying factors affecting magnesium (Mg) status that assist in providing improved evidence-based clinical decision-making for assessing Mg status.
INTRODUCTION
Magnesium (Mg) is a cofactor for over 600 enzymatic reactions vital to metabolic pathways including DNA, RNA, protein, and adenosine-5 0 -triphosphate synthesis; cellular energy production and storage; glycolysis; and cellular second messenger systems. As it has so many critical functions, body Mg is well regulated through three main mechanisms: first, absorption through the gastrointestinal tract, second, renal excretion after filtration-reabsorption, and third, exchange from the large pool in bone [1] . During low intakes of Mg, the percentage absorbed from the diet is increased, the amount excreted in the urine is decreased, and bone reserves are used. When dietary intakes are adequate, the opposite occurs.
The strong response of the body to maintain Mg homeostasis has made it difficult to establish status indicators for Mg. In addition, mild and moderate Mg deficiencies (subclinical Mg deficiency) are mostly asymptomatic [2 & ]. As a result, subclinical Mg deficiency has not been routinely recognized in healthy population groups. Nonetheless, relatively low Mg intakes, serum Mg concentrations, and urinary Mg excretions have been associated with critical health issues, including cardiovascular disease [3,4,5 & ,6] , type 2 diabetes [7 & ,8,9] , prediabetes [10 & ], and chronic kidney disease [11, 12] . These associations often did not correlate with an Mg deficiency as defined by the currently designated serum clinical reference range. The lack of correlation raises the question about the ability to assess Mg status to determine the presence of subclinical Mg deficiency. The lack justifies a review of current research to determine whether there is an improved method for evaluating Mg status, and a need for a revised clinical reference range for serum Mg.
SERUM MAGNESIUM
A review of recent literature indicates that total serum Mg concentration is the predominant, but unreliable, clinical test used to assess Mg status. The reference interval used for total serum Mg concentration was determined by measuring Mg in 15 820 'healthy normal individuals' aged 18-74 years in the 1974 National Health and Nutrition Examination Survey 1. The central 95th percentile was established as the 'normal' range for Mg, which resulted in a reference interval of 0.75-0.95 mmol/l [13] . This reference interval likely is not reflective of environmental conditions and eating habits of Americans today. For example, Mg intakes apparently have decreased because of such factors as lower amounts of Mg in processed foods and 'fast foods' and a lower consumption of whole grains, and fruits and vegetables. In addition, over 99% of total body Mg (22-26 g for an adult) is extravascular -mostly in the bones (>50%) and less than 1% in the serum [1] (Fig. 1) . Thus, serum Mg may not necessarily reflect true total body Mg content. This conclusion is supported by controlled metabolic unit studies with postmenopausal women that found serum Mg concentrations responded slowly (several weeks) with changes from deficiency to adequacy or vice versa [ 
DIETARY MAGNESIUM
Dietary Mg also is used as a measure of Mg status. In the United States and Canada, Mg dietary reference intakes (DRIs) were set in 1997. For adults aged 19-30 years, and 31-70 years, respectively, recommended dietary allowances (RDAs) of 310 and 320 mg/day for women and 410 and 420 mg/day for men were set; estimated average requirements (EARs; average daily level of intake estimated to meet the requirements of 50% of healthy individuals) of 255 and 265 mg/day for women and 330 and 350 mg/day for men were set [16] . Controlled metabolic unit studies suggest that these DRIs need modification and that the DRIs are proportional to body weight [14 & ]. The studies indicated that the RDA and EAR may be 250 (or 3.57 mg/kg) and 175 mg/day (or 2.5 mg/kg), respectively, for a healthy individual. In 2010, the average weights of American women and men were 166.2 and 195.5 (75.54 and 88.9 kg), respectively [17] . Basing the DRIs on body weight would result in an average EAR and RDA for women and men of 189 and 270, and 222 and 317 mg/day, respectively. Close to half of the US population has been shown to consume less than the daily requirement (1997 EAR) of Mg from foods [18 & ] . Table 2 provides a list of high Mg food sources.
The efficiency of Mg uptake after ingestion is affected by its chemical form when given as a supplement and by dietary factors that can enhance (lactose, fructose, and glucose) or inhibit absorption (fiber, free fatty acids, oxalate, phytate, and high levels of zinc). Also, net Mg absorption increases with increasing Mg intake; however, fractional Mg absorption falls. Human studies using diets ranging from low to high have found absorption to range from 35 to 70%. However, with normal intakes, 30-40% of dietary Mg is absorbed [16] .
KEY POINTS
A simple, rapid, and accurate single measurement to assess total body Mg status is lacking.
A combination of serum, urinary, and dietary Mg may the most practical method to assess Mg status at present.
Improved, evidence-based Mg dietary reference intakes and serum reference range are needed.
Mg is a shortfall nutrient of public health concern.
Assessment of Mg status is important because deficiency has an impact on multiple chronic diseases, morbidity, and mortality. ]. However, it was found that urinary Mg excretion changed rapidly between these two ranges (within a few days) upon changing from below to equal or above the current RDA, or vice versa. This rapid change indicates that a single determination of 24-h urinary Mg would be best used to support other Mg status indicators, or in the evaluation of Mg status of population groups. Analysis of datasets from subsets the Nurses' Health Study I and II and the Health Professionals Follow-up Study found that the population 24-h urinary excretion of Mg, among other urinary biomarkers measured, was stable upon repeated measurements within 1 year. The intraclass correlation coefficients (ICC) and reliability index described provide a measure of reproducibility of the sample over time. They further calculated a reliability index (the mean of a very large number of repeat measurements) to further evaluate reproducibility. For Mg excretion, the ICC was found to be at least 0.70 with a reliability index of at least 0.80. Thus, these investigators suggest that biomarkers such as urinary Mg measured on several timepoints are potentially useful for the assessment of various nutritional and environmental exposures in epidemiologic studies [19 && ].
MAGNESIUM STATUS INDICATORS AND THEIR ASSOCIATION WITH CARDIOVASCULAR DISEASES
In the vast majority of prospective and cross-sectional studies, serum, urinary, and dietary Mg have been inversely associated with hypertension and BP. This is exemplified by a recent systematic review and meta-analysis of prospective cohort studies that found a dose-response between dietary Mg and hypertension with intakes below 250 mg/day by visual inspection of the displayed figure [20] . A longitudinal analysis of heart failure diagnosis in the Jackson Heart Study cohort involving 4916 African Americans free of heart failure but with other comorbidities found the median gap from the baseline visit to initiation of heart failure was 1837 days with 270 incident cases being reported. Participants in the first quartile of Mg intake (0.52-2.30 mg/day/kg body wt, approx 181 mg/day) had an increased risk of heart failure hospitalization compared with those in the remaining quartiles (>2.30 mg/day/kg body wt) [hazard ratio (HR) of 0.66 and a 95% confidence interval (CI) of 0.47-0.94]. In the Atherosclerosis Risk in Communities Study, a low serum Mg (<70 mmol/l) was associated with a 70% higher ]. Over 30 RCTs using a range of formulations and doses of oral Mg in normotensive patients and hypertensive patients provide a rich source of data on serum and urinary Mg with changes in BP. As noted for the cohort studies, these studies similarly show increases in serum or urinary Mg with oral Mg supplementation along with variable results on BP. In the meta-analysis by Zhang et al. [3] , after a median dose of 368 mg/day for a median duration of 3 months in 2028 patients, SBP was reduced by 2.0 mmHg (95% CI 0.43-3.58) and DBP by 1.78 mmHg (95% CI 0.73-2.82) with a noted rise of 0.05 mmol/l in serum Mg. A more targeted metaanalysis that included 11 studies (543 patients) enrolling individuals with insulin resistance, prediabetes, or noncommunicable chronic disease found that Mg supplementation (365-450 mg/day) for a median of 3.6 months resulted in a mean reduction in SBP of 4.18 mmHg (standardized mean difference, À0.20; 95% CI À0.37 to À0.03) and 2.27 mmHg in DBP (À0.29; 95% CI À0.46 to À0.12) [22] . The authors of this meta-analysis concluded that the magnitude of BP reduction is of great clinical significance when applied at the public health level.
MAGNESIUM STATUS INDICATORS AND THEIR ASSOCIATION WITH THE METABOLIC SYNDROME AND DIABETES
Mg deficiency is not only a feature of diabetes but also frequently observed in individuals with prediabetes and/or the metabolic syndrome. Most recent support of this relationship is provided by the Canadian Health Measures Survey cycle 3 conducted between 2012 and 2013 that determined serum Mg concentrations in patients aged 3-79 years. Type I or type 2 diabetes was associated with 0.04-0.07 mmol/l lower serum Mg compared with not having diabetes. Serum Mg concentration was negatively associated with diabetes, BMI, serum glucose, serum insulin, hemoglobin A1c, and homeostatic model assessment of insulin resistance [23 && ]. This study also found that substantial proportions of the adult sex-age groups (9.5-16.6%) and adolescents of 12-19 years (15.8-21.8%) had serum Mg concentrations less than 0.75 mmol/l, currently accepted as an indication of Mg deficiency.
Another recent systematic review and metaanalysis of observational studies found a less robust association between serum Mg and the metabolic syndrome (mean difference: À0.19; 95% CI À0.36 to À0.03; P ¼ 0.023) [24 & ]. However, increased Mg intake (not defined) was highly associated with a lower risk of the metabolic syndrome [odds ratio (OR): 0.73, 95% CI 0.62-0.86; P < 0.001].
An analysis of data from 8555 participants enrolled in the population-based Rotterdam Study found, in the fully adjusted statistical model, that participants with hypomagnesemia (not defined) had an increased risk of developing diabetes over a median follow-up of 5.7 years (HR of 1.79 and a 95% CI of 1.16-2.77). Hypomagnesemic patients were at risk for developing prediabetes over a median follow-up of 5.7 years, which was not statistically significant in fully adjusted models. A unit of 0.1 mmol/l decrease in serum Mg concentrations was associated with an increased risk of both prediabetes and diabetes. This analysis also found that common genetic variants in Mg-regulating genes influenced diabetes risk and that the risk was mediated through serum Mg [10 & ] with the authors suggesting a potential causal role of Mg in the development of diabetes.
Analysis of dietary Mg intake data from 25 prospective cohort studies involving 637 922 patients with 26 828 incident cases of type 2 diabetes found, after adjusting for age and BMI, the risk of developing diabetes was reduced by 8-13% per 100 mg/day increment in dietary Mg intake [7 & ].
MAGNESIUM STATUS INDICATORS AND THEIR ASSOCIATION WITH BONE HEALTH
Serum Mg plays an important role in bone and mineral homeostasis. Deficient Mg can directly affect bone by altering the structure of apatite crystals. Mg deficiency is also associated with reductions of parathyroid hormone and 1,25(OH 2 ) D levels and inflammation, all of which can lead to bone loss.
Both experimental and epidemiological studies suggest that both low and high serum Mg concentrations are associated with changes in bone health [25] . Postmenopausal women with osteoporosis are noted to have consistently lower serum Mg concentrations across studies than their healthy controls. Men, but not women, enrolled in the European Prospective Investigation into Cancer and Nutrition-Norfolk cohort showed significant inverse trends in fracture risk across serum Mg concentration groups for spine fractures (P ¼ 0.02) and total hip, spine, and wrist fractures (P ¼ 0.02). The mean serum Mg for men was 0.81 AE 0.12 mmol/l [26] . Similarly, for 2245 men aged 42-61 participating in the Kuopio Ischemic Heart Disease prospective cohort study found that low serum Mg levels with comparable dietary intakes were strongly and independently associated (HR: 2.10, 0.74 mmol/l bottom quartile of serum Mg to top quartile, 0.89 mmol/l; 95% CI 1.30-3.41) with increased risk of total and femoral fractures [27] .
The effect of Mg intake on bone indices such as bone mineral density (BMD) is unclear and the data are mixed. Mg intake was evaluated with respect to BMD and fractures, measured at multiple sites, in a systematic review of 24 studies that included both men and women (118 664 patients 0.8 months to 67.7 years) and in an accompanying meta-analysis that included 12 studies. These authors found that high intakes of Mg (not defined) were not significantly associated with an increased risk of hip (summary effect size 1.92; 95% CI 0.81-4.55) and total fractures (1.01; 0.94-1.07). However, a high degree of heterogeneity was present in this small subgroup dataset. In addition, they noted a positive and marginally significant correlation between Mg intake and femoral neck and total hip BMD based on nine studies.
MAGNESIUM STATUS INDICATORS AND THEIR ASSOCIATION WITH CHRONIC KIDNEY DISEASE
Hypomagnesemia has been shown to be an emerging risk factor for incident chronic kidney disease [11, 12] . 
SUMMARY
Mg has been characterized as a shortfall nutrient of public health concern in America [18 & ]. Data from prospective cohort studies and small focused RCTs show strong correlation of Mg deficiency with increased risk of several chronic diseases, some of which exist as comorbidities. The data are convincing that there may be a relationship, but we do not know the type of relationship. The articles linking low Mg to disease in this review are all associative data (except for BP). What is needed to advance the field are Mg supplementation studies to test whether the association is causal. However, a simple, rapid, and reliable single measurement to determine the presence of Mg deficiency is lacking. Each of the three most commonly used indicators of Mg status has shortcomings. The serum reference range is questionable; individuals with Mg concentrations between 0.75 and 0.85 mmol/l are possibly deficient. DRIs apparently need revision and likely change with body weight. Urinary Mg responds too quickly to changes in dietary Mg intakes. However, because each status indicator can be strengthened by the addition of one or both of the other indicators, a combination of all three indicators would be the most practical method to assess Mg status.
CONCLUSION
At present, a combined determination of serum Mg concentration and urinary Mg excretion along with a dietary Mg history seems to be the propitious choice to get a valid assessment of Mg status. Mg deficiency should be considered as contributing to some chronic diseases and associated morbidities if patients exhibit a combined serum Mg less than 0.85 mmol/l, urinary Mg excretion less than 80.0 mg/day, and/Mg intakes less than 250 mg/day.
